ANTH — Anthera Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$8.08m
Annual cashflow statement for Anthera Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30.9 | -29.6 | -35.2 | -55.5 | -26.9 |
| Depreciation | |||||
| Non-Cash Items | 4.33 | 3.62 | 3.54 | 6.74 | 4.98 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.73 | 0.039 | 0.487 | -0.401 | -15.3 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -31.9 | -25.6 | -30.9 | -48.9 | -36.9 |
| Capital Expenditures | -0.015 | 0 | -0.08 | -0.766 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4.67 | 10 | 0 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.69 | 10 | -0.08 | -0.766 | 0 |
| Financing Cash Flow Items | -2.67 | -18.1 | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 43.1 | -7.71 | 75.3 | 23.6 | 18.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.51 | -23.3 | 44.3 | -26.1 | -18.6 |